Tong Ren Tang Technologies Co. Ltd. provided revenue guidance for the six months ended 30 June 2023. For the period, the company expects that the Group is expected to record an increase in its revenue by approximately 28% to 32%, and an increase in its net profit attributable to owners of the Company by approximately 13% to 17% for the six months ended 30 June 2023, as compared with the corresponding period last year.

The increase in revenue and net profit in the Period was mainly due to the sustained policy support of traditional Chinese medicine industry, the gradual release of social recognition and brand influence of the Group's products, which resulted in the continuous expansion of demand on the Group's products. In addition, under the guidance of the Group's strategy of "large variety", measures such as integration of channels, strengthening the control and empowering sales terminal constantly drove the increase in the Group's product sales.